MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
1.50
+0.15 (+11.52%)
At close: 3:52PM EDT
Stock chart is not supported by your current browser
Previous Close1.35
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume11,330
Market Cap21.72M
Beta2.79
PE Ratio (TTM)19.74
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017
    Capital Cube2 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017

    Categories: Yahoo FinanceGet free summary analysis MusclePharm Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of MusclePharm Corp. – GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (GNC-US, MYL-US and BMY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of MSLP earnings conference call or presentation 14-Aug-17 8:30pm GMT

    Q2 2017 MusclePharm Corp Earnings Call

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017
    Capital Cube5 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 16, 2017

    Categories: Yahoo FinanceGet free summary analysis MusclePharm Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of MusclePharm Corp. – GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (GNC-US, MYL-US and BMY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
    Capital Cube7 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis MusclePharm Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of MusclePharm Corp. – Natural Alternatives International, Inc., GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (NAII-US, GNC-US, MYL-US and BMY-US) that have also reported for this ... Read more (Read more...)

  • Arnold Schwarzenegger Lost A Bundle On Musclepharm Corp (MSLP), Says Hasta La Vista
    Insider Monkey8 months ago

    Arnold Schwarzenegger Lost A Bundle On Musclepharm Corp (MSLP), Says Hasta La Vista

    Arnold Schwarzenegger is known as a shrewd investor. Unfortunately he lost more than 80% on at least some of his investments in Musclepharm Corp (MSLP) over the last 3.5 years. During the summer of 2013 Arnold Schwarzenegger -one of the greatest muscle growth champions of all time- disclosed a 7.7 stake in MSLP whose shares […]

  • MusclePharm Corp. :MSLP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
    Capital Cube11 months ago

    MusclePharm Corp. :MSLP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016

    Categories: Yahoo Finance Get free summary analysis MusclePharm Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of MusclePharm Corp. – Natural Alternatives International, Inc., GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (NAII-US, GNC-US, MYL-US and BMY-US) that have also reported for this ... Read more (Read more...)

  • Bloomberglast year

    How MusclePharm Went From Swole to Twig

    For years, Brad Pyatt’s supplement company bulked up on celebrity endorsements and penny stock trades. Then the SEC started kicking sand in its face.